AMP-dependent protein kinase alpha 2 isoform promotes hypoxia-induced VEGF expression in human glioblastoma

GLIA

Volumn 53, Issue 7, 2006, Pages 733-743

  Neurath, Kathryn M ^a   Keough, Martin P ^a   Mikkelsen, Tom ^b   Claffey, Kevin P ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

AMPK; Glioma; HIF 1; Hypoxia; VEGF

Indexed keywords

5 IODOTUBERCIDIN; ADENOSINE PHOSPHATE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE ALPHA 1; CYCLIC AMP DEPENDENT PROTEIN KINASE ALPHA 2; HYPOXIA INDUCIBLE FACTOR 1; ISOENZYME; MESSENGER RNA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; ASTROCYTE; CANCER GRADING; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REPRESSION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MICROENVIRONMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

BRAIN NEOPLASMS; CELL HYPOXIA; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; DOWN-REGULATION; ENZYME INHIBITORS; GLIOBLASTOMA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; MULTIENZYME COMPLEXES; NEOVASCULARIZATION, PATHOLOGIC; OXIDATIVE STRESS; PROTEIN ISOFORMS; PROTEIN-SERINE-THREONINE KINASES; RNA INTERFERENCE; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TUBERCIDIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33646247392     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20326     Document Type: Article

References (44)

1. Arsham AM, Howell JJ, Simon MC. 2003. A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets. J Biol Chem 278:29655-29660.
2. Brat DJ, Castellano-Sanchez AA, Hunter SB, Pecot M, Cohen C, Hammond EH, Devi SN, Kaur B, Van Meir EG. 2004. Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population. Cancer Res 64:920-927.
3. Brat DJ, Kaur B, Van Meir EG. 2003. Genetic modulation of hypoxia induced gene expression and angiogenesis: relevance to brain tumors. Front Biosci 8:d100-116.
4. Broholm H, Laursen H. 2004. Vascular endothelial growth factor (VEGF) receptor neuropilin-1's distribution in astrocytic tumors. APMIS 112:257-263.
5. Carling D. 2004. The AMP-activated protein kinase cascade - a unifying system for energy control. Trends in Biochem Sci 29:18-24.
6. Claffey K, Robinson G. 1996. Regulation of VEGF/VPF expression in tumor cells: consequences for tumor growth and metastasis. Cancer and Metastasis Reviews 15:165-176.
7. Claffey KP, Brown LF, del Aguila LF, Tognazzi K, Yeo KT, Manseau EJ, Dvorak HF. 1996. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res 56:172-81.
8. Claffey KP, Shih SC, Mullen A, Dziennis S, Cusick JL, Abrams KR, Lee SW, Detmar M. 1998. Identification of a human VPF/VEGF 3′ untranslated region mediating hypoxia-induced mRNA stability. Mol Biol Cell 9:469-481.
9. Denko NC, Fontana LA, Hudson KM, Sutphin PD, Raychaudhuri S, Altman R, Giaccia AJ. 2003. Investigating hypoxic tumor physiology through gene expression patterns. Oncogene 22:5907-5914.
10. Dvorak HF. 2000. VPF/VEGF and the angiogenic response. Semin Perinatol 24:75-78.
11. Fedele AO, Whitelaw ML, Peet DJ. 2002. Regulation of gene expression by the hypoxia-inducible factors. Mol Intervent 2:229-243.
12. Folkman J, Watson K, Ingber D, Hanahan D. 1989. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339:58-61.
13. Frederich M, Zhang L, Balschi JA. 2005. Hypoxia and AMP independently regulate AMP-activated protein kinase activity in heart. Am J Physiol Heart Circ Physiol 288:H2412-2421.
14. Hardie DG. 1999. Roles of the AMP-activated/SNF1 protein kinase family in the response to cellular stress. Biochem Soc Symp 64:13-27.
15. Hardie DG, Carling D. 1997. The AMP-activated protein kinase - fuel gauge of the mammalian cell? Eur J Biochem 246:259-273.
16. Hardie DG, Scott JW, Pan DA, Hudson ER. 2003. Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett 546:113-120.
17. Helfman T, Falanga V. 1993. Gene expression in low oxygen tension. Am J Med Sci 306:37-41.
18. Hong YH, Varanasi US, Yang W, Leff T. 2003. AMP-activated protein kinase regulates HNF4alpha transcriptional activity by inhibiting dimer formation and decreasing protein stability. J Biol Chem 278:27495-27501.
19. Hwang J-T, Lee M, Jung S-N, Lee H-J, Kang I, Kim S-S, Ha J. 2004. AMP-activated protein kinase activity is required for vanadate-induced hypoxia-inducible factor 1(alpha) expression in DU145 cells. Carcinogenesis: 2004:25;2497-2507.
20. Inoki K, Zhu T, Guan KL. 2003. TSC2 mediates cellular energy response to control cell growth and survival. Cell 115:577-590.
21. Jorgensen SB, Viollet B, Andreelli F, Frosig C, Birk JB, Schjerling P, Vaulont S, Richter EA, Wojtaszewski JFP. 2004. Knockout of the {alpha}2 but not {alpha}1 5′-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-{beta}-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. J Biol Chem 279:1070-1079.
22. Kaur B, Tan C, Brat DJ, Van meir EG. 2004. Genetic and hypoxic regulation of angiogenesis in gliomas. Journal of Neuro-Oncology 70:229-243.
23. Kimura N, Tokunaga C, Dalal S, Richardson C, Yoshino K, Hara K, Kemp BE, Witters LA, Mimura O, Yonezawa K. 2003. A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway. Genes Cells 8:65-79.
24. Krause U, Bertrand L, Hue L. 2002. Control of p70 ribosomal protein S6 kinase and acetyl-CoA carboxylase by AMP-activated protein kinase and protein phosphatases in isolated hepatocytes. Eur J Biochem 269:3751-3759.
25. Lee JW, Bae SH, Jeong JW, Kim SH, Kim KW. 2004. Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp Mol Med 36:1-12.
26. Lee M, Hwang J-T, Lee H-J, Jung S-N, Kang I, Chi S-G, Kim S-S, Ha J. 2003. AMP-activated protein kinase activity is critical for hypoxia-inducible factor-1 transcriptional activity and its target gene expression under hypoxic conditions in DU145 cells. J Biol Chem 278:39653-39661.
27. Liu W, Saint DA. 2002. Validation of a quantitative method for real time PCR kinetics. Biochem Biophys Res Commun 294:347-353.
28. Marsin A-S, Bouzin C, Bertrand L, Hue L. 2002. The stimulation of glycolysis by hypoxia in activated monocytes is mediated by AMP-activated protein kinase and inducible 6-phosphofructo-2-kinase. J Biol Chem 277:30778-30783.
29. Maxwell PH, Pugh CW, Ratcliffe PJ. 2001. The pVHL-hIF-1 system. A key mediator of oxygen homeostasis. Adv Exp Med Biol 502:365-376.
30. Maxwell PH, Ratcliffe PJ. 2002. Oxygen sensors and angiogenesis. Semin Cell Dev Biol 13:29-37.
31. Michiels C. 2004. Physiological and pathological responses to hypoxia. Am J Pathol 164:1875-1882.
32. Nagata D, Mogi M, Walsh K. 2003. AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress. J Biol Chem 278:31000-31006.
33. Semenza GL. 1999. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15:551-578.
34. Semenza GL. 2000. HIF-1: using two hands to flip the angiogenic switch. Cancer Metastasis Rev 19:59-65.
35. Shih S-C, Claffey KP. 1998. Hypoxia-mediated regulation of gene expression in mammalian cells. Int J Experimental Pathology 79:347-357.
36. Shih SC, Mullen A, Abrams K, Mukhopadhyay D, Claffey KP. 1999. Role of protein kinase C isoforms in phorbol ester-induced vascular endothelial growth factor expression in human glioblastoma cells. J Biol Chem 274:15407-15414.
37. Stapleton D, Mitchelhill KI, Gao G, Widmer J, Michell BJ, Teh T, House CM, Fernandez CS, Cox T, Witters LA, et al. 1996. Mammalian AMP-activated protein kinase subfamily. J Biol Chem 271:611-614.
38. Viollet B, Andreelli F, Jorgensen SB, Perrin C, Flamez D, Mu J, Wojtaszewski JF, Schuit FC, Birnbaum M, Richter E, et al. 2003a. Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models. Biochem Soc Trans 31:216-219.
39. Viollet B, Andreelli F, Jorgensen SB, Perrin C, Geloen A, Flamez D, Mu J, Lenzner C, Baud O, Bennoun M, et al. 2003b. The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. J Clin Invest 111:91-98.
40. Woods A, Azzout-Marniche D, Foretz M, Stein SC, Lemarchand P, Ferre P, Foufelle F, Carling D. 2000. Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase. Mol Cell Biol 20:6704-6711.
41. Woods A, Vertommen D, Neumann D, Turk R, Bayliss J, Schlattner U, Wallimann T, Carling D, Rider MH. 2003. Identification of phosphorylation sites in AMP-activated protein kinase (AMPK) for upstream AMPK kinases and study of their roles by site-directed mutagenesis. J Biol Chem 278:28434-28442.
42. Young LH, Li J, Baron SJ, Russell RR. 2005. AMP-activated protein kinase: a key stress signaling pathway in the heart. Trends in Cardiovascular Med 15:110-118.
43. Yun H, Lee M, Kim S-S, Ha J. 2005. Glucose deprivation increases mRNA stability of vascular endothelial growth factor through activation of AMP-activated protein kinase in DU145 prostate carcinoma. J Biol Chem 280:9963-9972.
44. Zagzag D, Zhong H, Scalzitti JM, Laughner B, Simons JW, Semenza GL. 2000. Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression. Cancer 88:2606-2618.